Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
9
×
boston blog main
life sciences
boston top stories
life science
national
national blog main
national top stories
event
drugs
antibiotics
arvinas
astrazeneca
bioinnovation capital
biolabs
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
celgene
chemotherapy
clinical trials
daraprim
detroit
detroit blog main
detroit top stories
drug pricing
entasis therapeutics
epipen
epipens
exome
fda
gene therapy
generic drugs
gritstone oncology
guardant health
indiana
indiana blog main
indiana top stories
What
life
9
×
medical
9
×
sciences
accelerating
attend
biopharma's
biopharma’s
boston
breakthroughs
digital
future
health
learn
registering
team
tech
xcelerating
join
online
biotech
biotechs
bird
chose
close
company
device
driving
drug
early
ends
firms
good
healthcare
history
improved
industry
innovation
innovations
investment
ipo
Language
unset
Current search:
medical
×
life
×
boston
×
@xconomy.com
4 years ago
Join us this Wednesday for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Join Us Online May 13 for Xcelerating Life Sciences: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way